Page last updated: 2024-09-03

sr 48692 and amiloride hydrochloride, anhydrous

sr 48692 has been researched along with amiloride hydrochloride, anhydrous in 1 studies

Compound Research Comparison

Studies
(sr 48692)
Trials
(sr 48692)
Recent Studies (post-2010)
(sr 48692)
Studies
(amiloride hydrochloride, anhydrous)
Trials
(amiloride hydrochloride, anhydrous)
Recent Studies (post-2010) (amiloride hydrochloride, anhydrous)
2033361205

Protein Interaction Comparison

ProteinTaxonomysr 48692 (IC50)amiloride hydrochloride, anhydrous (IC50)
serine/threonine-protein kinase D1 isoform 2Homo sapiens (human)6.8848
serine/threonine-protein kinase PLK1Homo sapiens (human)6.629
Estrogen receptor betaMus musculus (house mouse)6.8848
Estrogen receptorMus musculus (house mouse)6.8848
Muscarinic receptor M1 Bos taurus (cattle)6.8848

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for sr 48692 and amiloride hydrochloride, anhydrous

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013